Nanoliposomal Irinotecan in Head & Neck and Esophagus After Prior Platinum-based Chemotherapy or Chemoradiotherapy

Condition:   Head & Neck Cancer Intervention:   Drug: nanoliposomal irinotecan Sponsors:   National Health Research Institutes, Taiwan;   China Medical University Hospital;   Tri-Service General Hospital;   Taipei Veterans General Hospital, Taiwan;   National Cheng-Kung University Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials